Literature DB >> 3439884

Kinetics of hydrolysis in vitro of nornitrogen mustard, a metabolite of phosphoramide mustard and cyclophosphamide.

K Hemminki1, A Alhonen, E Linkola, A Hesso.   

Abstract

A gas chromatographic (GC-ECD) method was developed for the determination of nornitrogen mustard (NOR) and its hydrolysis products. The method was based on derivatization by heptafluorobutyric anhydride. The structures of the derivatives of NOR were established by GC-MS. The method was used to characterize the rate of transformation of NOR and phosphoramide mustard (PAM), important metabolites of cyclophosphamide, into secondary products in vitro at 37 degrees C and pH 7.4. The rate of disappearance of NOR had a half-life of 20 min. The half-life of appearance of N-(2-chloroethyl)-N-(2-hydroxyethyl)amine (NOR-OH) was 19 min. While most NOR appeared to be converted to NOR-OH, the yield of N,N-bis(2-hydroxyethyl)amine (NOR-OH-OH) was a small fraction of the starting material. The disappearance of NOR, when PAM was used as a starting material, had a half-life of 19 min; in these experiments NOR-OH and NOR-OH-OH were relatively much more abundant compared to when NOR was used as the starting material.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439884     DOI: 10.1007/BF00661370

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  17 in total

1.  Identification of phosphorodiamidic acid mustard as a human metabolite of cyclop hosphamide.

Authors:  C Fenselau; M N Kan; S Billets; M Colvin
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

2.  Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite.

Authors:  R F Struck; M C Kirk; M H Witt; W R Laster
Journal:  Biomed Mass Spectrom       Date:  1975-02

3.  Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans.

Authors:  C Fenselau; M N Kan; S S Rao; A Myles; O M Friedman; M Colvin
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

4.  Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.

Authors:  I Jardine; C Fenselau; M Appler; M N Kan; R B Brundrett; M Colvin
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

5.  Role of aldehyde dehydrogenase in the metabolism-dependent biological activity of cyclophosphamide.

Authors:  J H Hipkens; R F Struck; H L Gurtoo
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

6.  Alkylating properties of phosphoramide mustard.

Authors:  M Colvin; R B Brundrett; M N Kan; I Jardine; C Fenselau
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

7.  Mutagenic activities of cyclophosphamide (NSC-26271) and its main metabolites in Salmonella typhimurium, human peripheral lymphocytes and Chinese hamster ovary cells.

Authors:  K Winckler; G Obe; S Madle; H Nau
Journal:  Mutat Res       Date:  1984-10       Impact factor: 2.433

8.  DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide.

Authors:  K Hemminki
Journal:  Chem Biol Interact       Date:  1987-01       Impact factor: 5.192

9.  [Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)].

Authors:  T Wagner; D Heydrich; G Voelcker; H J Hohorst
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553

10.  Identification of new metabolites of phosphoramide and nor-nitrogen mustards and cyclophosphamide in rat urine using ion cluster techniques.

Authors:  K K Chan; S C Hong; E Watson; S K Deng
Journal:  Biomed Environ Mass Spectrom       Date:  1986-03
View more
  1 in total

1.  Substrate-Coated Illumination Droplet Spray Ionization: Real-Time Monitoring of Photocatalytic Reactions.

Authors:  Hong Zhang; Na Li; Dandan Zhao; Jie Jiang; Hong You
Journal:  J Am Soc Mass Spectrom       Date:  2017-05-17       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.